Overview A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of titrated KWA-0711 dose in chronic constipation patients. Phase: Phase 2 Details Lead Sponsor: Kissei Pharmaceutical Co., Ltd.